Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_905600260521fc45e86d226a761c8936 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e616a466c908ac40f2dbd08f206991d |
publicationDate |
2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2017214315-A |
titleOfInvention |
Diphenylpyrazole derivatives and their pharmaceutical use |
abstract |
To provide a compound having an action of inhibiting the protease activity of MALT1 and useful as a therapeutic or prophylactic agent for autoimmune diseases such as multiple sclerosis and psoriasis. The present invention provides a diphenylpyrazole derivative represented by the following formula or a pharmacologically acceptable salt thereof. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018159650-A1 |
priorityDate |
2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |